Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Preveceutical Medical Inc PRVCF


Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based... see more

Recent & Breaking News (CSE:PREV)

Winning the War on Diabetes & Obesity: a $2.5 Trillion Solution

Jeff Nielson July 14, 2017

PreveCeutical Closes Private Placement and Reverse Take-Over Transaction and Announces Resumption of Trading

Stockhouse.com July 10, 2017

Carrara gets CSE green light for PreveCeutical amalgamation

Stockhouse Editorial June 22, 2017

CARRARA RECEIVES CONDITIONAL ACCEPTANCE FROM CSE FOR ACQUISITION OF PREVECEUTICAL ANNOUNCES NAME CHANGE, SHARE CONSOLIDATION AND CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT

Stockhouse.com June 22, 2017

Update: PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer

Stockhouse.com May 17, 2017

PreveCeutical sees opportunity in research deal with UniQuest

Stockhouse Editorial April 24, 2017

PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Extraction, Formulation and Ex Vivo Evaluation of Cannabinoids (“CBD”s) for Delivery via Sol-Gels

GlobeNewswire April 24, 2017

PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Development of Caribbean Blue Scorpion Venom-Derived Natural & Synthetic Peptides

GlobeNewswire April 20, 2017

PreveCeutical unveils cannabinoid, diabetes products deal with UniQuest

Stockhouse Editorial April 13, 2017

PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest Pty Limited

GlobeNewswire April 13, 2017

IIROC Trading Halt - CAA

Canada NewsWire March 21, 2017

IIROC Trade Resumption - CAA

Canada NewsWire February 17, 2017

IIROC Trading Halt - CAA

Canada NewsWire February 17, 2017